Larimar Therapeutics | Investor Presentation Deck | 32 slides · page 12 of 32
The chart displays a longitudinal study of FXN concentration across different dose groups (Placebo, 25mg, 50mg, 100mg) at Baseline, Day 4/7, and Day 13.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 1/1 list 2/2 source-note 1/1 title 2/2
Components 6
dot bullet bullet source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.